{
    "clinical_study": {
        "@rank": "19907", 
        "acronym": "AVATAR", 
        "arm_group": [
            {
                "arm_group_label": "Antiarrhythmic drugs", 
                "arm_group_type": "Active Comparator", 
                "description": "Flecainide or Propafenone or Sotalol (oral, standard dosage)"
            }, 
            {
                "arm_group_label": "ABLATION", 
                "arm_group_type": "Experimental", 
                "description": "Catheter Ablation"
            }
        ], 
        "brief_summary": {
            "textblock": "A randomized, parallel, open study comparing catheter ablation versus antiarrhythmic drugs\n      for outflow tract ventricular arrhythmias"
        }, 
        "brief_title": "Catheter Ablation Versus Antiarrhythmic Drugs for Outflow Tract Ventricular ARrhythmias", 
        "condition": [
            "Ventricular Tachycardia", 
            "Ventricular Premature Complexes"
        ], 
        "condition_browse": {
            "mesh_term": [
                "Tachycardia", 
                "Tachycardia, Ventricular", 
                "Ventricular Premature Complexes"
            ]
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n        1. presence of ventricular ectopic beats (VEB) with left-bundle-branch block morphology or\n        right-bundle-branch block morphology and positive concordance throughout the chest leads,\n        inferior axis and at least one of the following:\n\n          1. >2000 isolated VEB/24h\n\n          2. symptomatic monomorphic ventricular tachycardia\n\n          3. left ventricular disfunction supposed to be due to tachycardia-induced cardiomyopathy\n\n        Exclusion Criteria:\n\n          1. known structural heart disease\n\n          2. pregnancy\n\n          3. life expectancy < 1 year"
            }, 
            "gender": "Both", 
            "healthy_volunteers": "No", 
            "maximum_age": "80 Years", 
            "minimum_age": "18 Years"
        }, 
        "firstreceived_date": "January 25, 2013", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT01780311", 
            "org_study_id": "Arezzo008"
        }, 
        "intervention": [
            {
                "arm_group_label": "Antiarrhythmic drugs", 
                "intervention_name": "antiarrhythmic drugs (Flecainide or Propafenone or Sotalol)", 
                "intervention_type": "Drug"
            }, 
            {
                "arm_group_label": "ABLATION", 
                "intervention_name": "Catheter Ablation", 
                "intervention_type": "Procedure"
            }
        ], 
        "intervention_browse": {
            "mesh_term": [
                "Anti-Arrhythmia Agents", 
                "Propafenone", 
                "Flecainide", 
                "Sotalol"
            ]
        }, 
        "is_fda_regulated": "No", 
        "lastchanged_date": "January 30, 2013", 
        "location": {
            "contact": {
                "email": "notarstefano2001@yahoo.it", 
                "last_name": "Pasquale Notarstefano, MD"
            }, 
            "facility": {
                "address": {
                    "city": "Arezzo", 
                    "country": "Italy", 
                    "state": "AR", 
                    "zip": "52100"
                }, 
                "name": "Cardiovascular Department, Ospedale S.Donato"
            }, 
            "investigator": [
                {
                    "last_name": "Leonardo Bolognese, MD, FESC", 
                    "role": "Principal Investigator"
                }, 
                {
                    "last_name": "Pasquale Notarstefano, MD", 
                    "role": "Principal Investigator"
                }, 
                {
                    "last_name": "Simone Grotti", 
                    "role": "Sub-Investigator"
                }
            ], 
            "status": "Recruiting"
        }, 
        "location_countries": {
            "country": "Italy"
        }, 
        "overall_status": "Recruiting", 
        "oversight_info": {
            "authority": "Italy: Ethics Committee", 
            "has_dmc": "No"
        }, 
        "phase": "Phase 4", 
        "primary_completion_date": {
            "#text": "January 2014", 
            "@type": "Anticipated"
        }, 
        "primary_outcome": {
            "description": "Quality of life improvement according to SF-36 score variations", 
            "measure": "SF-36 score", 
            "safety_issue": "No", 
            "time_frame": "6 months"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT01780311"
        }, 
        "responsible_party": {
            "investigator_affiliation": "Ospedale San Donato", 
            "investigator_full_name": "Leonardo Bolognese, MD", 
            "investigator_title": "Director", 
            "responsible_party_type": "Principal Investigator"
        }, 
        "source": "Ospedale San Donato", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "Ospedale San Donato", 
                "agency_class": "Other"
            }
        }, 
        "start_date": "January 2013", 
        "study_design": "N/A", 
        "study_type": "Interventional", 
        "verification_date": "January 2013"
    }
}